Is the prognosis of patients with a first admission for heart failure improving with the increased use of ACE inhibitors?
Observational data suggests an improving prognosis for first-time heart failure admissions, temporally associated with increased ACE inhibitor utilization.
These data suggest that the prognosis of patients with a first admission for heart failure is improving. The timing of improvement coincides with the gradual increase in the use of angiotensin converting enzyme inhibitors for heart failure although a causal link cannot be proved from these data.
Cleland et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: